Bill > H1093

This bill establishes new regulations for prescription pain medication coverage in Florida's Medicaid program and Medicaid managed care plans. Specifically, the bill defines a "nonopioid pain drug" as a non-opioid medication approved by the U.S. Food and Drug Administration for pain treatment, and requires that such drugs be given equal treatment to opioid and narcotic pain medications. The bill prohibits several practices that could disadvantage nonopioid pain drugs, including designating them as nonpreferred drugs when opioid drugs are preferred, and establishing more restrictive utilization controls such as more burdensome prior authorization or step-therapy requirements. These provisions apply to both the state Medicaid agency and Medicaid managed care plans, with the goal of ensuring that patients have fair access to non-opioid pain management options. The bill is set to take effect on July 1, 2025, and aims to provide more balanced and flexible pain treatment options for Medicaid recipients by preventing potential barriers to nonopioid pain medication access.

Health and Social Services

https://www.flsenate.gov/Session/Bill/2025/1093